Actively Recruiting
Evaluating Topical Clascoterone 1% Cream Compared to Adapalene 0.1% Cream for Treating Mild-to-Moderate Acne Vulgaris
Led by Pak Emirates Military Hospital · Updated on 2026-10-22
130
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of two topical creams, clascoterone 1% and adapalene 0.1%, in treating mild-to-moderate acne vulgaris, a skin condition causing blackheads, whiteheads, pimples, and inflammation. This randomized controlled trial includes 130 participants aged 12 to 40 years, aiming to compare these treatments in a clinical setting. Participants will be randomly assigned to one of two groups one group will apply clascoterone 1% cream twice daily, while the other group will apply adapalene 0.1% cream once daily at night. Both groups will receive advice on gentle cleansing, moisturizer use, avoiding picking acne lesions, and using sunscreen. Treatment will last for 12 weeks with assessments at Weeks 4, 8, and 12. During the study, researchers will collect baseline information and evaluate treatment success by measuring changes in acne severity using the Investigators Global Assessment score and lesion counts. They will also monitor treatment compliance, adverse effects such as skin irritation, and patient satisfaction. Follow-up visits ensure ongoing safety and effectiveness assessments throughout the 12-week period.
CONDITIONS
Brief Title
Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne Vulgaris
Research Team
D
Dr Zeshan Akhtar, MBBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here